GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
15:01 Jul 10, 2008 |
French to English translations [Non-PRO] Medical - Medical: Pharmaceuticals | |||||
---|---|---|---|---|---|
|
| ||||
| Selected response from: Drmanu49 France Local time: 13:51 | ||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
4 +1 | paste (drug presentation) or here non-paste presentation of a drug |
| ||
4 +1 | paste formulation |
|
paste (drug presentation) or here non-paste presentation of a drug Explanation: Check the label on the medicine for exact dosing instructions. ... Triamcinolone Drug Interactions. Compare Triamcinolone Paste with other medications for ... www.drugs.com/cdi/triamcinolone-paste.html - 42k or here non-paste presentation of a drug |
| |
Grading comment
| ||
Login to enter a peer comment (or grade) |
paste formulation Explanation: http://216.239.59.104/search?q=cache:0WREwET349wJ:www.sato-s... paste formulation Multi-spike release formulation for oral drug delivery - Patent ... The drug formulation may be in the form of a suspension, capsule, tablet, paste, gel, or solid or semi-solid form such as a “candy bar”. ... www.freepatentsonline.com/6555127.html - 37k - Cached - Similar pages Amlexanox paste is currently marketed in the United States under the trademark Apthasol™ and is also available in Japan in a tablet formulation for the treatment of asthma. A Notice of Compliance was received from the Therapeutic Products Programme on December 11th, 2000. Paladin Labs Inc. would be the distributor of this product in Canada and they expect to launch the product early in the year 2001. At this time, the exact mechanism of action by which amlexanox causes accelerated healing of aphthous ulcers is unknown. Amlexanox, an antiallergic agent, is a potent inhibitor of the formation and/or release of inflammatory mediators from cells including neutrophils and mast cells. As soon as a canker sore is discovered, a small amount of paste (i.e., 0.5 cm) is applied four times daily to each ulcer. Treatment is continued until the ulcer is healed. Should no significant healing or pain relief be apparent after 10 days of use, medical or dental advice should be sought. Apthera® is expected to be available as a 5% paste formulation in Canada. -------------------------------------------------- Note added at 31 mins (2008-07-10 15:32:54 GMT) -------------------------------------------------- WO94/25070 discloses oral composition containing a proton pump inhibitor in the form of enteric coated dry particles mixed with a dry gelling agent, the mixture may then be made into a paste-like gel prior to administration. The composition therefore requires enteric coating, with the afore-mentioned disadvantages associated with such formulation. Furthermore, because such a moist gel is not stable during long-term storage at room temperature it cannot be manufactured and sold as a ready-to-use formulation, rather it must be prepared ex tempore at the time of administration, making it inconvenient to use. The formulation described herein is a stable, ready to use semi-solid paste formulation containing a proton pump inhibitor suitable for administering to animals such as horses, cattle, pig etc, and human beings with difficulty swallowing solid dosage forms such as tablets and capsules. The present invention can be easily administered to horses and is readily accepted by these animals. The formulation of the present invention is stable during long-term storage at room temperature. or even pharmaceutical paste-formulation |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.